|
| 34907091 | BAP1-deficient meningioma presenting with trabecular architecture and cytokeratin expression: a report of two cases and review of the literature. | J Clin Pathol | 2023 |
| 37619659 | Fractionated radiotherapy for surgically resected intracranial meningiomas: A multicentre retrospective cohort study. | Radiother Oncol | 2023 |
| 37541501 | Technical, economic and environmental analysis of solar thermochemical production of drop-in fuels. | Sci Total Environ | 2023 |
| 37188783 | Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. | Nat Med | 2023 |
| 37171636 | Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. | Acta Neuropathol | 2023 |
| 37434550 | Methylation Profiling Identifies Stability of Isocitrate Dehydrogenase Mutation Over Time. | Can J Neurol Sci | 2023 |
| 37164978 | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Nat Commun | 2023 |
| 36748749 | DNA methylation profiling of a lipomatous meningioma: illustrative case. | J Neurosurg Case Lessons | 2023 |
| 36840836 | The multiomic landscape of meningiomas: a review and update. | J Neurooncol | 2023 |
| 36455236 | Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification. | Neuro Oncol | 2023 |
| 36757134 | Identification of structural scaffold from interbioscreen (IBS) database to inhibit 3CLpro, PLpro, and RdRp of SARS-CoV-2 using molecular docking and dynamic simulation studies. | J Biomol Struct Dyn | 2023 |
| 34431452 | Strategic analyses to identify key structural features of antiviral/antimalarial compounds for their binding interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2: <i>in silico</i> molecular docking and dynamic simulation studies. | J Biomol Struct Dyn | 2022 |
| 35668302 | A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL. | Brain Tumor Pathol | 2022 |
| 34614192 | DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma. | Neuro Oncol | 2022 |
| 33025139 | Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Acta Neuropathol | 2021 |
| 33925295 | Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors. | Int J Mol Sci | 2021 |
| 34433969 | A clinically applicable integrative molecular classification of meningiomas. | Nature | 2021 |
| 33112994 | Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Acta Neuropathol | 2021 |
| 32572265 | Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes. | Nat Med | 2020 |
| 31758290 | Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. | Cell Biol Toxicol | 2020 |
| 33062411 | Global RNA editome landscape discovers reduced RNA editing in glioma: loss of editing of gamma-amino butyric acid receptor alpha subunit 3 (GABRA3) favors glioma migration and invasion. | PeerJ | 2020 |
| 30401645 | Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes. | Gene | 2019 |
| 30808902 | Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma. | Sci Rep | 2019 |
| 30781903 | Nâ¶-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling. | Genes (Basel) | 2019 |
| 29263181 | Loss-of-Function Mutations in Calcitonin Receptor (<i>CALCR</i>) Identify Highly Aggressive Glioblastoma with Poor Outcome. | Clin Cancer Res | 2018 |
| 30077762 | A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma. | Gene | 2018 |
| 30206628 | Iodine-catalyzed cross-coupling of isocyanides and thiols for the synthesis of S-thiocarbamates. | Org Biomol Chem | 2018 |
| 30038703 | Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma. | Oncotarget | 2018 |
| 28485999 | IGF2 mRNA binding protein 3 (IMP3) mediated regulation of transcriptome and translatome in glioma cells. | Cancer Biol Ther | 2018 |
| 28991227 | Essential role of METTL3-mediated m<sup>6</sup>A modification in glioma stem-like cells maintenance and radioresistance. | Oncogene | 2018 |
| 27212030 | Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration. | Oncogene | 2017 |
| 28378523 | Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor. | Mol Oncol | 2017 |
| 28465487 | IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65. | Oncotarget | 2017 |
| 28392842 | DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas. | Clin Epigenetics | 2017 |
| 28035070 | Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma. | Oncotarget | 2017 |
| 27993893 | Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low- and high-grade astrocytic tumors. | Carcinogenesis | 2017 |
| 27291091 | Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription. | Sci Rep | 2016 |
| 27871300 | PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA. | Mol Cancer | 2016 |
| 27382437 | Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastoma. | Genes Cancer | 2016 |
| 25823686 | Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate. | Nat Commun | 2015 |
| 26245897 | Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis. | J Biol Chem | 2015 |
| 26496030 | Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing. | Oncotarget | 2015 |
| 26390214 | An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals. | PLoS One | 2015 |
| 26232108 | Definition of a serum marker panel for glioblastoma discrimination and identification of Interleukin 1β in the microglial secretome as a novel mediator of endothelial cell survival induced by C-reactive protein. | J Proteomics | 2015 |
| 26191359 | Left-Hand Side Exploration of Novel Bacterial Topoisomerase Inhibitors to Improve Selectivity against hERG Binding. | ACS Med Chem Lett | 2015 |
| 26001493 | Advances in industrial prospective of cellulosic macromolecules enriched banana biofibre resources: A review. | Int J Biol Macromol | 2015 |
| 24703230 | Design and synthesis of triazolopyrimidine acylsulfonamides as novel anti-mycobacterial leads acting through inhibition of acetohydroxyacid synthase. | Bioorg Med Chem Lett | 2014 |
| 24809953 | Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis. | J Med Chem | 2014 |
| 24923441 | Methylation silencing of ULK2, an autophagy gene, is essential for astrocyte transformation and tumor growth. | J Biol Chem | 2014 |
| 24914738 | Aminoazabenzimidazoles, a novel class of orally active antimalarial agents. | J Med Chem | 2014 |